Daniel J. Sexton
39Patents
8h-index
39Co-inventors
71Inventor score
Filing activity: Aug 3, 2005 → Apr 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7329737B2 | Antibodies that bind hK-1 | Physics | 36 | Expired |
| US8816055B2 | Plasma kallikrein binding proteins | Physics | 24 | Active |
| US8822653B2 | Plasma kallikrein binding proteins | Chemistry; Metallurgy | 21 | Active |
| US9266964B2 | Method of treating hereditary angioedema using plasma kallikrein binding antibodies | Physics | 20 | Active |
| US10370453B2 | Plasma kallikrein binding proteins | Physics | 17 | Active |
| US11084884B2 | Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema | Chemistry; Metallurgy | 14 | Active |
| US10428158B2 | Compositions and methods for treatment of diabetic macular edema | Chemistry; Metallurgy | 10 | Active |
| US10336832B2 | Methods of inhibiting plasma kallikrein in edema patient | Chemistry; Metallurgy | 9 | Active |
| US8642010B2 | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy | Emerging Cross-Sectional Technologies | 8 | Active |
| US11046785B2 | Compositions and methods for treatment of diabetic macular edema | Chemistry; Metallurgy | 7 | Active |
| US7993646B2 | HK1-binding proteins | Physics | 7 | Active |
| US9359438B2 | Human neonatal Fc receptor antibodies and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US10101344B2 | Diagnosis and treatment of autoimmune diseases | Physics | 5 | Active |
| US10648990B2 | Diagnosis and treatment of autoimmune diseases | Physics | 4 | Active |
| US9862768B2 | Methods of producing antibodies to neonatal Fc receptor (FcRn) | Chemistry; Metallurgy | 3 | Active |
| US10914747B2 | Immunoassay to detect cleaved high molecular weight kininogen | Physics | 3 | Active |
| US11401346B2 | Nucleic acids encoding plasma kallikrein binding proteins | Physics | 3 | Active |
| US11340237B2 | Metabolite biomarkers for diseases associated with the contact activation system | Physics | 3 | Active |
| US10913802B2 | Monoclonal antibody inhibitor of factor XIIA | Chemistry; Metallurgy | 3 | Active |
| US10479834B2 | Fc receptor antibodies and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US11505620B2 | Methods of detecting plasma kallikrein | Chemistry; Metallurgy | 2 | Active |
| US11156612B2 | Methods of determining levels of cleaved and/or intact kininogen | Physics | 2 | Active |
| US10870115B2 | Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation | Physics | 2 | Active |
| US11372002B2 | Assays for determining plasma kallikrein system biomarkers | Physics | 1 | Active |
| US12084515B2 | Compositions and methods for treatment of diabetic macular edema | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.